Return to Article Details INTEGRATIVE ANALYSIS OF PHARMACOTHERAPY, BIOMARKERS, AND BIOMEDICAL MECHANISMS IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES MELLITUS